Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2PX in post-herpetic neuralgia (enriched enrollment, randomized withdrawal)
2005-003739-32Phase 2Terminated
- Sponsor
- SantoSolve
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing 2PX maintenance arm with Placebo withdrawal arm (2 arms). Primary endpoint: Time to exit during double-blind phase. Started Jan 2006; status: terminated.
02
Drugs
strontium chloride hexahydrate
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2005-003739-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003739-32.